Seguimiento farmacoterapéutico en pacientes con Diabetes mellitus tipo 2 atendidos en consulta externa del Centro de Salud Tipo C de Saquisilí, provincia de Cotopaxi

Abstract

The main purpose of this research study was to identify drug-related problems (DRP) and negative results associated with medication (NRM) in the Health Center Type C of Saquisilí. For which a quasi-experimental, quantitative, prospective, and longitudinal design was applied. The Dáder method of pharmacotherapeutic follow-up was applied, which consists of seven stages: service offer, first interview, situation status, study phase, evaluation, action plan, and result of the intervention. The sample was made up of thirty patients with type 2 diabetes mellitus who agreed to be part of the study in the period May-August 2021. In order to measure the degree of adherence to pharmacological treatment, the Morisky Green Levine test was applied. The results showed 113 DRPs that caused the appearance of 90 NRM, of which 77% were solved. In the evaluation of the clinical parameters, the T-test student with a level of significance of 0.05, obtaining basal glucose a p=0.0034, postprandial glucose p=0.0018, triglycerides p=0.0022, total cholesterol p=0.0030, blood pressure systolic p=0.0123 and diastolic blood pressure p=0.0027 accepting the alternative hypothesis for values less than 0.05 establishing that there is a significant difference, in addition to adherence to drug therapy increased from 10% to 60% after the pharmaceutical intervention. It was concluded that the development of pharmacotherapeutic follow-up generated a positive impact for that patients carry optimal management of the disease in order to meet the therapeutic objectives established through a necessary, effective, and safe pharmacotherapy. Therefore, it is recommended to implement this service in health establishments to reduce drug-related morbidity and mortality by providing them with information in such a way that it is understood drug therapy and the importance of adherence to it.